{"id":431862,"title":"Notice: Multiple additions to the Prescription Drug List (PDL) [2025-06-24] - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-02","captureTimestamp":"2026-01-02T06:49:09.211000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/multiple-additions-2025-06-24.html","snippet":"Notice: Multiple additions to the Prescription Drug List (PDL) [2025-06-24] June 24, 2025 Our file number: 25-104183-77 The purpose of this Notice of Amendment is to notify about the addition of cipaglucosidase alfa, delafloxacin, elafibranor, lazertinib, omaveloxolone,…","rawSnapshotUrl":"/api/snapshots/raw/431862","browseUrl":"https://replay.healtharchive.ca/job-6/20260102064909/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/multiple-additions-2025-06-24.html#ha_snapshot=431862","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}